Cerus Corp (CERS.O)

CERS.O on Consolidated Issue listed on NASDAQ Global Market

4.11USD
22 Oct 2014
Price Change (% chg)

$-0.08 (-1.91%)
Prev Close
$4.19
Open
$4.19
Day's High
$4.19
Day's Low
$4.01
Volume
878,341
Avg. Vol
831,298
52-wk High
$8.00
52-wk Low
$3.48

CERS.O

Chart for CERS.O

About

Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on the Company's technology for controlling biological replication, is designed to inactivate blood-borne pathogens in donated blood components intended for... (more)

Overall

Beta: 1.91
Market Cap (Mil.): $310.26
Shares Outstanding (Mil.): 74.05
Dividend: --
Yield (%): --

Financials

  CERS.O Industry Sector
P/E (TTM): -- 31.12 33.54
EPS (TTM): -0.48 -- --
ROI: -61.41 8.65 17.61
ROE: -68.93 12.01 18.42
Search Stocks

Competitors

  Price Change
Terumo Corp (4543.T) ¥2,439 +59.00
Grifols SA (GRLS.MC) €31.68 +1.18
Grifols SA (GRLSbn.MC) €26.11 +0.45

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks